Indel Therapeutics is engaged in the development of new drugs to address the global health crisis caused by antibiotic resistance.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Vancouver
State: British Columbia
Zip:
Country: Canada
Indel Therapeutics Inc. is a Vancouverâ€based biopharmaceutical company dedicated to developing new drugs to address the global health crisis caused by antibiotic resistance. The Company has a growing pipeline of novel antibiotic drug discovery programs focused on curing difficultâ€toâ€treat and hospitalâ€acquired infections. These programs are based on Indel&s;s paradigmâ€changing antimicrobial drug discovery platform, a patented technology that that has opened a rich, new area of antimicrobial drug targets for the treatment of infectious diseases and has the potential to provide an advantage against drug resistance.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2011 | Series B | $0 |
MAD Ventures Morningside Group Quantum Pacific Capital MAD Ventures Morningside Group Quantum Pacific Capital |
9/2008 | Series A | - | 4/2011 | Series B | 3 | $1.4M |
MAD Ventures Morningside Group Quantum Pacific Capital MAD Ventures Morningside Group Quantum Pacific Capital |
9/2008 | Series A | - |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|